Emma Noto

On 26th October 2022, Emma was diagnosed with metastatic embryonal Rhabdomyosarcoma after a mass was discovered in her neck. She had just turned 3 years old.

She went on to have nine rounds of IVADO chemotherapy and 28 rounds of radiotherapy. Maintenance protocol followed for 4 months before Emma sadly relapsed. A new tumour was discovered in her nasal cavity. She travelled to the Princess Maxima Centre, Netherlands where she received AMORE treatment, alongside 11 rounds of VIT chemotherapy. Her care was led from Great Ormond Street Hospital, London.

Sadly, a second relapse came a few months later with a new tumour located in the mastoid bone behind her right ear. Curative treatment options had ran out. Tragically, Emma passed away in December 2025 surrounded by her beloved family. She is loved and missed beyond words.

Emma's Story...

Emma filled every room she walked into. She was funny, curious and full of energy. She loved singing and dancing, adored Paddington and princesses. She was happiest when surrounded by the people she loved. Whether she was writing stories, making people laugh or sitting around the dinner table chatting with family, she approached life with enthusiasm and joy.

She was also incredibly caring and remarkably resilient. Even when faced with challenges that would overwhelm most adults, Emma somehow found a way to keep smiling, keep learning and keep looking forward to the next adventure. She often talked about wanting a job where she could help and rescue people one day. That was Emma.

The summer before her diagnosis was one of the happiest we could remember. We spent it in Pornic, France Emma’s happy place. She celebrated her third birthday there, surrounded by sunshine, family and everything she loved – ice cream, croissants and her family. She was her usual bubbly, energetic self. Looking back, there were tiny signs that something wasn’t quite right. Her voice sounded a little nasal and she had started snoring at night despite not having a cold. We mentioned it to the GP and pharmacist, but both reassured us it was likely a minor viral infection or blocked sinuses. We had no reason to think otherwise.

When we returned home in September. It was then we found a lump in Emma’s neck. Again, we were reassured it was probably linked to an infection. To be on the safe side, we were sent to paediatric A&E, where Emma had her first cannula fitted. I will never forget holding my little girl while she screamed in pain. The doctors explained that enlarged lymph nodes were common in young children and that there was nothing to suggest anything serious. Emma had no other symptoms. She was eating normally, full of energy and running around as she always had. An ultrasound appeared reassuring. She was given intravenous antibiotics followed by oral antibiotics and we continued attending review appointments.

For weeks, we heard the same message. Nothing to worry about. But we could see the lump growing every day. Eventually, before another scheduled review, we pushed for a further scan. This time everything changed. The scan revealed a large mass in Emma’s neck and we were referred to Great Ormond Street Hospital. Even then, we struggled to believe anything serious could be wrong. Emma looked so well.

At Great Ormond Street, events moved quickly. Emma underwent an MRI under general anaesthetic, followed by a biopsy. I can still picture the room where we were given the diagnosis. Until that moment, we had clung to the belief that there would be another explanation. Emma was still laughing, playing and filling every room with energy.When the consultant told us it was rhabdomyosarcoma, it felt as though we couldn’t breathe. We had never heard the word before, but we understood the word that came after it: cancer. Everything changed in an instant. One moment we were planning nursery days, birthdays and family adventures. The next, we were being introduced to treatment plans, central lines and chemotherapy.

Two days later, Emma had a central line fitted and began treatment immediately. By that point, the tumour had already caused paralysis on the right side of her face. The chemotherapy worked quickly and the tumour began shrinking almost immediately. But further investigations revealed a suspicious mass on her spine. After weeks of review by specialists across the country, it was concluded that the cancer had most likely spread and Emma’s treatment plan changed to one designed for metastatic disease. Suddenly, our lives revolved around hospital appointments, scans and treatment schedules. Emma lost her hair after her first round of chemotherapy. Because of the tumour’s location, surgery was not possible. Instead, she underwent nine rounds of chemotherapy and 28 sessions of radiotherapy under general anaesthetic. 

One of the brightest moments during treatment was the arrival of her baby sister, Claire. In the middle of hospital appointments, chemotherapy and uncertainty, Claire brought joy. Emma loved being a big sister from the very beginning. Despite everything she was facing herself, she was endlessly caring towards Claire. Watching them together was a reminder that cancer had not changed who Emma was. She was still the same loving little girl she had always been. When treatment ended and scans showed no evidence of disease, we finally allowed ourselves to hope. Maintenance chemotherapy meant more time at home and less time in hospital. Emma returned to nursery, spent time with friends and her cousins and started enjoying childhood again. Her central line was replaced with a port, meaning she could finally have baths and go swimming once more. For a short while, life felt a little lighter.

Then came the relapse. A biopsy unexpectedly found cancer cells in scar tissue despite clear scans. There was no visible tumour on MRI. All we could do was wait. We spent months hoping there had been some mistake, desperately wishing the cancer had not returned. Instead, we found ourselves in the impossible position of waiting for it to grow enough for doctors to treat it. During this time, we travelled to the Princess Máxima Centre in the Netherlands because it represented something we desperately needed: hope. Emma immediately loved it there. The music room, toys, bicycles and play specialists brought her much happiness. While we worried about scans, treatment plans and impossible decisions, Emma remained focused on the things children should be focused on playing, laughing and having fun. When scans later confirmed tumour growth, Emma became eligible for AMORE treatment at the Princess Máxima Centre. AMORE is a highly specialised treatment combining major surgery with targeted brachytherapy. It was invasive, carried significant risks and required us to place our trust in a treatment that was not available to Emma through standard NHS care pathways in the UK. As parents, it was a daunting decision. But our options were becoming increasingly limited and we were determined to explore every possibility.

Emma faced the treatment with the same courage and determination she showed throughout her cancer journey. The road afterwards was not easy, but the treatment was successful. It gave us something priceless. Time. Time for school days and holidays. Time for family adventures. Time for laughter, memories and moments that we will treasure forever. Most importantly, it gave Emma more time to be a child. It was followed by 11 more rounds of chemotherapy, which became increasingly difficult for Emma. She suffered severe stomach pain, diarrhoea, a complete loss of appetite and significant weight loss. Eventually she required feeding through a PEG tube and became very weak. Yet one thing never changed. Her love of school. School became Emma’s happy place. She loved learning, loved being with her friends and loved being part of everyday life. Whenever she was well enough, she wanted to be there. Her determination to keep going despite everything she was facing inspired everyone around her.

By early 2025, treatment had become so difficult that doctors decided the risks of continuing outweighed the benefits. Her final planned cycle of chemotherapy was cancelled. Slowly, Emma began to recover. We enjoyed holidays, days out, Disneyland and precious time together as a family. Her PEG and port were removed. She returned to school and regained some of her strength. We knew there was a significant risk the cancer would return, but we hoped for time.

Then, in July, our world changed once again. Emma came home from school with paralysis on the right side of her face – the same symptom she had experienced at diagnosis. We knew. Even before the scans confirmed it. An emergency MRI revealed another tumour. Surgery was performed to relieve pressure and remove as much of the tumour as possible. Afterwards, we were told there were no longer any curative options. The focus would now be on slowing the cancer and giving Emma the best possible quality of life.

Shortly afterwards, we returned to France one final time.Emma’s happy place. Deep down, we knew it would be our last visit there together. The months that followed were some of the hardest of our lives. But they were also filled with love and memories. There was camping, Halloween celebrations with friends, a safari park visit, a holiday in the New Forest, a pamper day, a day as a nurse, time with firefighters and a magical day with Santa. Even while living with pain and uncertainty, Emma remained determined to make the most of every moment.

As the cancer progressed, the Palliative Care Team provided extraordinary support at home, helping to manage Emma’s symptoms and allowing us precious time together as a family. In November, scans confirmed the cancer had spread to her brain. We knew time was running short. We brought Emma home, where she was surrounded by cuddles, love and the people who mattered most.

One day she quietly said:

“Mummy, I feel different. My body feels different. I used to run and climb, now I’m just tired. I don’t feel like doing the things I used to love.”

No parent should ever hear those words from their child.

As she became increasingly sleepy and unwell, she was transferred to Noah’s Ark Children’s Hospice. Emma spent just under two weeks there. The specialist nursing care she received ensured she was peaceful, comfortable and surrounded by love. It gave us precious time together as a family – time to sit beside her, hold her hand and simply be together. Claire was able to spend time with her sister and create memories that we will treasure forever.

Emma died in December 2025. She was loved beyond words and is missed every single day yet her legacy lives on. It lives on in Claire, who will grow up hearing stories about the remarkable big sister who adored her. It lives on in the family, friends, nurses, doctors, teachers and countless others whose lives she touched. Emma faced more in her short life than most people face in a lifetime. Yet she met every challenge with a courage and resilience that never stopped amazing us.

What was your journey with cancer like?

When the consultant told us it was rhabdomyosarcoma, a type of  childhood cancer, it felt as though we couldn’t breathe. We had never heard the word before, but we understood the word that came after it: cancer.

Everything changed in an instant. One moment we were planning nursery days, birthdays and family adventures. The next, we were being introduced to treatment plans, central lines and chemotherapy.

The treatment was relentless. But Emma was remarkable. Time and again, she faced procedures, scans and treatment with a courage far beyond her years. She built friendships with nurses and doctors, adored the play specialists and continued to find joy wherever she could.

Emma’s story should not simply be remembered for the cancer she fought. It should be remembered for the little girl who loved to sing, dance, write stories and make people smile. The little girl who treasured her family, adored her sister and never stopped finding joy in the world around her.

Her life was far too short, but the impact she had on others will last forever. Because that was Emma.

What changes would you like to see for children diagnosed in the future?

We tell her story because children like Emma deserve better. Change needs to happen urgently. 

We need more research into childhood cancers. We need kinder and more effective treatments designed specifically for children. We need better outcomes for children whose cancer returns, and greater access to innovative treatments wherever they are available.

Most of all, families need hope.

 

News

Read all the latest fundraising news, charity news and commentary on childhood cancer.

Innovative research with the University of Oxford to explore the use of mRNA vaccines for treating RMS.
We are proud to share our Annual Report for 2023-2024. Please do take the time to read.
First RMS research grant made in the USA in collaboration with St. Baldricks EPICC team.
Read all about what happened from 1st October 2022 to 30th September 2023 in our Annual Report.
Family Research Day at the Sanger Institute
This Request for Applications (RFA) in conjunction with SBF EPICC will lead to a $750K RMS research grant.
This incredible football fundraiser involving Neive’s community and professional footballers raised £5K.
A team of 105 runners comprising scientists, doctors, surgeons, nurses, pharmacists, families, friends, parents all ran together.
This incredible community event marked Mollie’s five year anniversary of her diagnosis with rhabdomyosarcoma.
An insight into life in the laboratory for Post Doc, Dr Christina Burke.
We are delighted to publish our Annual Report covering FY21/22.
Around the Wash Spiderman themed cycle in memory of Elliott Peto.
This high profile news coverage was showcased on 10th May 2023.
An article focussed on the Cancer Grand Challenge, NexTGen, featuring co-founder, Sara Wakeling.
On the 11th March 2023 families, medical professionals and scientists came together as a community.
The launch took place at a special memorial assembly at Elliott’s school.
We will be opening as a 501(c)(3) in 2023.
Press coverage received in Sunday’s Observer on 15th January 2023.
The sale of gold bath bombs throughout UK Lush stores raises £150K.
Pilot findings published in an article in the Journal of Clinical Oncology.
Our ‘Say My Name’ Season’s Greeting’s card are now available to buy.
Epic cycling challenge for Amber’s Arc raises over £11K.
Telling the stories of the inspirations behind our work is the focus for CCAM 2022
Alice’s Arc referenced in Washington Post news article discussing research in children’s cancers
Lush will be selling a ‘gold’ dragon’s egg bath bomb in support of Dexter’s Arc
An insight into life in the laboratory for Dr Joanna Selfe at the ICR.
The Alice’s Arc annual report covering 1st October 2020 to 30th September 2021.
Alice’s Arc is delighted to be collaborating with CCLG to deliver this research to improve the treatment decision-making process for families.
Delighted to discuss progress on research regarding genetic markers of rhabdomyosarcoma and improving treatment therapies.
They took part in the London West 10kms Tough Mudder in support of Gaspard’s experience with rhabdomyosarcoma.
Sara Wakeling is a patient advocate on the Cancer Grand Challenge, NexTGen.
Delighted to be invited as speakers representing the parental perspective of rhabdomyosarcoma.
Please consider participating in a research interview as part of the REFoRMS (Relapsed and Refractory Rhabdomyosarcoma) study, led by the University of York.
On Tuesday 26th April 2022 this debate was held for the first time with 22 MPs speaking on behalf of constituents.
New research project aims to lead to better outcomes for children with the MYOD1 L122R mutation in fusion negative RMS.
2022 LLHM team of 18 runners raise £16K for research into rhabdomyosarcoma.
On 7th March 2022, we visited Great Ormond Street Hospital, where Alice’s care and treatment for rhabdomyosarcoma was led.
Alice’s Arc had the opportunity to meet the research team undertaking the rhabdomyosarcoma projects invested in and to tour the laboratories
The roles are for a Scientific Project Manager and a Statistician.
This is the first in a series of meet the Alice’s Arc researchers across our research projects.
This new work package will explore the targets identified in RMS model systems with a focus on clinical translation.
We are delighted to appear in the ICR’s latest edition of their twice-yearly Search magazine.
Freddie’s family are inviting you to become part of this special community this Easter and support Alice’s Arc
Will Rutt, aged 20, sadly passed away on Sunday 21st February 2021 after a four year journey with stage 4 ARMS
This project will increase understanding of RAS gene pathways in RMS with a focus on DNA repair and replication stress.
Having being touched by Gaspard’s journey with cancer, a member of staff nominated Alice’s Arc to receive a donation
Assessing The Clinical Value For ct-DNA In Blood To Monitor The Response To Treatments and Identify Disease Recurrence
300 of these candles incorporating Elsa’s very own artwork and name have been sold over the festive season
We are delighted to be supporting five innovative research projects led by several leading cancer research centres
Their daughter, Sophie, was recently diagnosed with rhabdomyosarcoma and her family are fundraising for the charity.
FaR-RMS opened in September 2020 and is now open in ten sites in England and Scotland and several sites across Europe.
On Friday 6th November 2020 Plan.com organised a turn ‘pink’ fundraising day for Alice’s Arc.
Phil and Vicky Macqueen both ran this virtual event in memory of their niece, Jessica Macqueen.
We worked closely with families impacted by cancer to help local communities and businesses ‘go gold’ and fundraise.
The pandemic of Covid-19 has made it mandatory to wear face coverings in certain settings. Why not buy one of ours?
A unique wing walk, in memory of Alice Wakeling and Freddie Carpenter and to go gold for children with cancer
In memory of Elsa McGee, her Dad and other family walked 125 miles over 5 days along the Leeds to Liverpool canal path
Covid-19 inspired Tom to grow his hair and transform himself in to the Tiger King to raise funds for Hope With Gaspard
To mark Faye’s 5th birthday and as a way of giving back since Faye’s cancer diagnosis, her Aunt and Grandad ran 10kms
Please read this edition of our Annual Report to get a snapshot of our activity for the year and our future plans.
Alice’s school choose Alice’s Arc as their charity of the year for the 2019/20 academic school year
Elsa sadly died in April 2020 and her parents want the funds raised to contribute to research in to rhabdomyosarcoma.
Generous support for the charity enabled us to create goody bags for children with cancer receiving chemotherapy at GOSH
Natalie, a trainee psychologist, is the mother of two boys, both diagnosed with cancer within months of one another.
After a 4 year battle, Elsa sadly passed away from embryonal rhabdomyosarcoma on April 14th 2020.
Alice’s school organised a fun run, on Saturday 14th March 2020, in Knole Park for the whole school and their families.
We hosted 85 people at St Julian’s Club, Sevenoaks on Saturday 14th March 2020 at a ‘Go Gold’ casino fundraising event
Sara was delighted to take up the opportunity to attend this reception in celebration of International Woman’s Day
This tells Alice’s cancer story from her point of view and illustrates the mission and progress of Alice’s Arc
The club supported the charity in 2019 and ran several fundraising initiatives including a quiz.
There have been various fundraising initiatives put in place around the firm’s network in memory of Alice Wakeling.
Local schools Walthamstow Hall Junior and New Beacon held Valentine’s fundraising events
Up Up and Away and Alice’s Arc enjoyed visiting the oncology wards with heart balloons, sweet cones and chocolate hearts
Are you feeling lucky? Please join us for a gold casino fundraising evening raising money for Alice’s Arc.
The Edward Gostling Foundation supports people living with long-term illnesses
Jess Macqueen passed away from rhabdomyosarcoma just 5 months after her diagnosis
We are delighted to announce that, the newly formed fund, Hope With Gaspard, will raise funds for Alice’s Arc
Benjamin Ronsseray nominated the charity for this award following his son, Gaspard’s diagnosis with rhabdomyosarcoma.
The EpSSG meeting brings together international professionals devoted to treating children with soft tissue sarcoma
23 parents ran the Watford Autumn 10K in support of Alice’s Arc
Alice’s Arc has fulfilled it’s initial three year pledge to the ICR and given the team a further £69K for research
The school has already raised almost £10K. Latest fundraisers include the sale of the ‘Alice’ bow and a singing event .
8 cyclists rode over 240 miles from London to Paris over three days to raise funds for Alice’s Arc
On the 8th October 2019, Alice Wakeling passed away peacefully, after almost 5 years fighting rhabdomyosarcoma.
The charity had 14 runners participating in this stunning central London Half Marathon.
We have now donated almost £280K to the ICR team since the inception of the relationship in 2016.
This leaflet provides information on who we are, what we do, why we do it and how you can help.
Shane is taking on this challenge in August, cycling from Land’s End to John O’Groats, in memory of his nephew, Freddie.
Olivia Ruhen will work in a Postdoc role on the ICR’s rhabdomyosarcoma research team
Over 100 spectators braved snowy conditions to watch 45 people fire walk to raise funds to help children with cancer
We are delighted to be featured in an article in the ICR’s Spring 2019 edition of their Search magazine
Dunn AC Ltd is helping raise awareness and funds for the charity. They have added the logo to their fleet of vans
Alice’s recent scans show no evidence of cancer. The damage from the AMORE surgery and brachytherapy has healed.
In memory of Freddie Carpenter, Waitrose Rickmansworth, supported the charity with their community green coin scheme.
These funds have enabled the recruitment of a Clinical Research Fellow to add to the team researching rhabdo at the ICR.
The ICR has published a report called ‘From patent to patient – analysing access to innovative cancer drugs
We are delighted to share that the charity has raised over £250K since our inception 2.5 years ago.
It’s a huge tribute to a wonderful 5 year old. Donations to Alice’s Arc at Freddie’s funeral reached over £10K
Alice’s Arc is hosting a fire walk fundraiser in conjunction with the Mayor and local Sevenoaks Council
The ICR team continue to make progress researching rhabdomyosarcoma using the funds raised by Alice’s Arc
Finn’s mother arranged a fantastic event in Leigh-on-Sea, incorporating a quiz, a live auction and a raffle.
Team Cheek went on another colossal walk for the charity raising in excess of £3K
The family fun morning hosted by the school Alice attends raised in excess of £2K for the charity.
Finn, passed away from rhabdo, aged 10 after a courageous 18 month fight with the disease.
Two school girls create fresh lemonade recipe and set up a stall selling it at an event celebrating Armed Forces Day
The charity has received support from various individuals choosing to run and cycle to raise money for the charity
Mike ran the London Marathon in 3 hours and 2 minutes raising almost £4K in support of a family impacted by rhabdo
First Give and Hampstead School joined forces to help children support their community and pitch for their chosen causes
Choose Alice’s Arc when shopping on Amazon Smile UK and 0.5% of the purchase price will be donated to us
Alice is being treated using a relapse chemotherapy regime and a specialist procedure in Amsterdam known as AMORE
This money covers the salary of a Higher Scientific Officer to support the ICR’s rhabdomyosarcoma research.
Alice’s Arc has commented on a letter to President Juncker regarding delays to the reform of EU Paediatric Regulation.
The charity is delighted to have received support from accountants, Kingston Smith and a major US private equity house.
Allen & Overy will make an annual donation to support the mission of Alice’s Arc
We have provided funds to enable an injection of the drug, neulasta for a 3 year old boy suffering from rhabdomyosarcoma
The charity has provided the ICR with funds to acquire laboratory reagents and equipment
Current EU legislation allows Pharmas to use a loophole in EU legislation to avoid trialling cancer drugs in children
Paul raised over £2K shaving his 9 inch hair and beard off and donating it to the little princess charity
Make Believe Sevenoaks invited parents of children in their drama class to join in for a day to raise money for charity
Simon and Sandy Haddock showcased their recent art works at an art evening which raised £1K for Alice’s Arc
Rani completed a 25km walk across 16 London bridges raising £1K for Alice’s Arc.
Accenture nominated Alice’s Arc as one of three charities to donate funds raised from its annual OPSCARS auction
Matt Cheek and Dave Watts walked 100km in 24hours for Matt’s 3 year old nephew who has rhabdomyosarcoma.
Hands Decals - LeftCreated with Sketch.
Hands Decals - RightCreated with Sketch.

Our Mission

We have already raised £4,500,000 and now aim to reach £10,000,000 to pay for research to find a cure and better treatments for rhabdomyosarcoma.
Raised £4,500,000